Clinical trial
A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
NCT00457951 · Jazz Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00457951 |
|---|---|
| Title | A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD |
| Official title | An Open-Label Phase Followed by a Randomized, Double-Blind, Placebo-Controlled Phase in a Study Designed to Evaluate Intravenous 2-O, 3-O Desulfated Heparin (ODSH) in Subjects With Exacerbations of Chronic Obstructive Pulmonary Disease |
| Acronym | COPD |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Open-Label, Placebo Comparator: Placebo-Control Arm 0.9% Sodium Chloride, ODSH |
| Enrollment | 158 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Apr 9, 2007 |
| Last update posted | Dec 2, 2021 |
| Countries | Belgium, Canada, Germany, Poland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: